Biosimilar Drug Market Size, Share, Growth Statistics By Top Key Players | Henlius Biotech, Eli Lilly, CP Guojian

PRESS RELEASE

Published February 6, 2023

The global Biosimilar Drug market size was valued at USD 9907.55 million in 2021 and is expected to expand at a CAGR of 63.17% during the forecast period, reaching USD 187016.67 million by 2027.

Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this Biosimilar Drug Industry.

"Biosimilar Drug Market" Insights 2023 - By Applications (Cardiovascular, Rheumatoid Arthrtis, Tumor, Ankylosing Spondylitis), By Types (Tablets, Injection, Others), By Segmentation analysis, Regions and Forecast to 2028. The Global Biosimilar Drug market Report provides In-depth analysis on the market status of the Biosimilar Drug Top manufacturers with best facts and figures, meaning, Definition, SWOT analysis, PESTAL analysis, expert opinions and the latest developments across the globe., the Biosimilar Drug Market Report contains Full TOC, Tables and Figures, and Chart with Key Analysis, Pre and Post COVID-19 Market Outbreak Impact Analysis and Situation by Regions.

Browse Detailed TOC, Tables and Figures with Charts which is spread across 106 Pages that provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche sector.

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Biosimilar Drug market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Biosimilar Drug Industry

TO KNOW HOW COVID-19 PANDEMIC AND RUSSIA UKRAINE WAR WILL IMPACT THIS MARKET - REQUEST SAMPLE

This research report is the result of an extensive primary and secondary research effort into the Biosimilar Drug market. It provides a thorough overview of the market's current and future objectives, along with a competitive analysis of the industry, broken down by application, type and regional trends.It also provides a dashboard overview of the past and present performance of leading companies. A variety of methodologies and analyses are used in the research to ensure accurate and comprehensive information about the Biosimilar Drug Market.

Get a Sample PDF of report -https://www.360researchreports.com/enquiry/request-sample/21459432

Biosimilar Drug Market - Competitive and Segmentation Analysis:

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Key players in the global Biosimilar Drug market are covered in Chapter 9:

Henlius Biotech
Eli Lilly
CP Guojian
Changchun High Tech
Biotech
Novartis
Innovent
Celgen
Amgen

Short Description About Biosimilar Drug Market:

The Global Biosimilar Drug market is anticipated to rise at a considerable rate during the forecast period, between 2022 and 2028. In 2021, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

The global Biosimilar Drug market size was valued at USD 9907.55 million in 2021 and is expected to expand at a CAGR of 63.17% during the forecast period, reaching USD 187016.67 million by 2027.

Biosimilar therapy is defined as a therapy that is highly similar to approved biopharmaceuticals. They are made by converting biopharmaceuticals made from living cells in the laboratory into large-scale production molecules. This is quite different from the general treatment method, which is identical to the reference small molecule drug. The reason behind this is that it is impossible to make a copy of the same biologic drug.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Biosimilar Drug market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers and acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Get a Sample Copy of the Biosimilar Drug Report 2022

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 and 11.2.2.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

This Biosimilar Drug Market Research/Analysis Report Contains Answers to your following Questions

What are the global trends in the Biosimilar Drug market? Would the market witness an increase or decline in the demand in the coming years?
What is the estimated demand for different types of products in Biosimilar Drug? What are the upcoming industry applications and trends for Biosimilar Drug market?
What Are Projections of Global Biosimilar Drug Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
Where will the strategic developments take the industry in the mid to long-term?
What are the factors contributing to the final price of Biosimilar Drug? What are the raw materials used for Biosimilar Drug manufacturing?
How big is the opportunity for the Biosimilar Drug market? How will the increasing adoption of Biosimilar Drug for mining impact the growth rate of the overall market?
How much is the global Biosimilar Drug market worth? What was the value of the market In 2020?
Who are the major players operating in the Biosimilar Drug market? Which companies are the front runners?
Which are the recent industry trends that can be implemented to generate additional revenue streams?
What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Biosimilar Drug Industry?

Customization of the Report

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Inquire more and share questions if any before the purchase on this report at -https://www.360researchreports.com/enquiry/pre-order-enquiry/21459432

Detailed TOC of Global Biosimilar Drug Market Insights and Forecast to 2028

Table of Content

1 Biosimilar Drug Market Overview
1.1 Product Overview and Scope of Biosimilar Drug Market
1.2 Biosimilar Drug Market Segment by Type
1.2.1 Global Biosimilar Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Biosimilar Drug Market Segment by Application
1.3.1 Biosimilar Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Biosimilar Drug Market, Region Wise (2017-2027)
1.4.1 Global Biosimilar Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Biosimilar Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Biosimilar Drug Market Status and Prospect (2017-2027)
1.4.4 China Biosimilar Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Biosimilar Drug Market Status and Prospect (2017-2027)
1.4.6 India Biosimilar Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Biosimilar Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Biosimilar Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Biosimilar Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Biosimilar Drug (2017-2027)
1.5.1 Global Biosimilar Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Biosimilar Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Biosimilar Drug Market

2 Industry Outlook
2.1 Biosimilar Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Biosimilar Drug Market Drivers Analysis
2.4 Biosimilar Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Biosimilar Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Biosimilar Drug Industry Development

3 Global Biosimilar Drug Market Landscape by Player
3.1 Global Biosimilar Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Biosimilar Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Biosimilar Drug Average Price by Player (2017-2022)
3.4 Global Biosimilar Drug Gross Margin by Player (2017-2022)
3.5 Biosimilar Drug Market Competitive Situation and Trends
3.5.1 Biosimilar Drug Market Concentration Rate
3.5.2 Biosimilar Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers and Acquisitions, Expansion

4 Global Biosimilar Drug Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Biosimilar Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Biosimilar Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Biosimilar Drug Market Under COVID-19
4.5 Europe Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Biosimilar Drug Market Under COVID-19
4.6 China Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Biosimilar Drug Market Under COVID-19
4.7 Japan Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Biosimilar Drug Market Under COVID-19
4.8 India Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Biosimilar Drug Market Under COVID-19
4.9 Southeast Asia Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Biosimilar Drug Market Under COVID-19
4.10 Latin America Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Biosimilar Drug Market Under COVID-19
4.11 Middle East and Africa Biosimilar Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Biosimilar Drug Market Under COVID-19

5 Global Biosimilar Drug Sales Volume, Revenue, Price Trend by Type
5.1 Global Biosimilar Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Biosimilar Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Biosimilar Drug Price by Type (2017-2022)
5.4 Global Biosimilar Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Biosimilar Drug Sales Volume, Revenue and Growth Rate of Tablets (2017-2022)
5.4.2 Global Biosimilar Drug Sales Volume, Revenue and Growth Rate of Injection (2017-2022)
5.4.3 Global Biosimilar Drug Sales Volume, Revenue and Growth Rate of Others (2017-2022)

6 Global Biosimilar Drug Market Analysis by Application
6.1 Global Biosimilar Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Biosimilar Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biosimilar Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Biosimilar Drug Consumption and Growth Rate of Cardiovascular (2017-2022)
6.3.2 Global Biosimilar Drug Consumption and Growth Rate of Rheumatoid Arthrtis (2017-2022)
6.3.3 Global Biosimilar Drug Consumption and Growth Rate of Tumor (2017-2022)
6.3.4 Global Biosimilar Drug Consumption and Growth Rate of Ankylosing Spondylitis (2017-2022)

7 Global Biosimilar Drug Market Forecast (2022-2027)
7.1 Global Biosimilar Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Biosimilar Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Biosimilar Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Biosimilar Drug Price and Trend Forecast (2022-2027)
7.2 Global Biosimilar Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Biosimilar Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Biosimilar Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Biosimilar Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Biosimilar Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Biosimilar Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Biosimilar Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Biosimilar Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Biosimilar Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Biosimilar Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Biosimilar Drug Revenue and Growth Rate of Tablets (2022-2027)
7.3.2 Global Biosimilar Drug Revenue and Growth Rate of Injection (2022-2027)
7.3.3 Global Biosimilar Drug Revenue and Growth Rate of Others (2022-2027)
7.4 Global Biosimilar Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Biosimilar Drug Consumption Value and Growth Rate of Cardiovascular(2022-2027)
7.4.2 Global Biosimilar Drug Consumption Value and Growth Rate of Rheumatoid Arthrtis(2022-2027)
7.4.3 Global Biosimilar Drug Consumption Value and Growth Rate of Tumor(2022-2027)
7.4.4 Global Biosimilar Drug Consumption Value and Growth Rate of Ankylosing Spondylitis(2022-2027)
7.5 Biosimilar Drug Market Forecast Under COVID-19

8 Biosimilar Drug Market Upstream and Downstream Analysis
8.1 Biosimilar Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 RandD Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Biosimilar Drug Analysis
8.6 Major Downstream Buyers of Biosimilar Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Biosimilar Drug Industry

9 Players Profiles
9.1 Henlius Biotech
9.1.1 Henlius Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Biosimilar Drug Product Profiles, Application and Specification
9.1.3 Henlius Biotech Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Eli Lilly
9.2.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Biosimilar Drug Product Profiles, Application and Specification
9.2.3 Eli Lilly Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 CP Guojian
9.3.1 CP Guojian Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Biosimilar Drug Product Profiles, Application and Specification
9.3.3 CP Guojian Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Changchun High Tech
9.4.1 Changchun High Tech Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Biosimilar Drug Product Profiles, Application and Specification
9.4.3 Changchun High Tech Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biotech
9.5.1 Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Biosimilar Drug Product Profiles, Application and Specification
9.5.3 Biotech Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Novartis
9.6.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Biosimilar Drug Product Profiles, Application and Specification
9.6.3 Novartis Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Innovent
9.7.1 Innovent Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Biosimilar Drug Product Profiles, Application and Specification
9.7.3 Innovent Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Celgen
9.8.1 Celgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Biosimilar Drug Product Profiles, Application and Specification
9.8.3 Celgen Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Amgen
9.9.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Biosimilar Drug Product Profiles, Application and Specification
9.9.3 Amgen Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source

Purchase this report (Price 3250 USD for a single-user license) -https://www.360researchreports.com/purchase/21459432

About Us:

360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

For More Related Reports Click Here :

Sports-Nutrition-Ingredients-Market

Polyphenylene-Oxide-Market

Anti-Static-Tape-Market

Jerrycans-Market

Clothing-Accessories-Market

Leave-on-Masks-Market

Nutty-Toppings-Market

Glass-Bottle-Market

Stationary-Fuel-Market

Bauxite-Mining-Market

Lithium-Phosphate-Market